Author:
Takiguchi Kazuo,Uezato Akihito,Itasaka Michio,Atsuta Hidenori,Narushima Kenji,Yamamoto Naoki,Kurumaji Akeo,Tomita Makoto,Oshima Kazunari,Shoda Kosaku,Tamaru Mai,Nakataki Masahito,Okazaki Mitsutoshi,Ishiwata Sayuri,Ishiwata Yasuyoshi,Yasuhara Masato,Arima Kunimasa,Ohmori Tetsuro,Nishikawa Toru
Funder
Core Research for Evolutional Science and Technology
Grant-in-Aid for Scientific Research
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference38 articles.
1. Javitt DC, Balla A, Burch S, Suckow R, Xie S, Sershen H. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists. Neuropsychopharmacology. 2004;29(2):300–7.
2. Nishikawa T, Tanii Y, Umino A, Hashimoto A, Hata N, Takashima M, Shirayama Y, Takahashi K. Phencyclidine, NMDA receptor and schizophrenia. Yakubutsu Seishin Kodo. 1991;11(1):65–9.
3. Javitt DC. Glutamate as a therapeutic target in psychiatric disorders. Mol Psychiatry. 2004;9(11):984–97. 979
4. Tsai GE, Yang P, Chang YC, Chong MY. D-alanine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 2006;59(3):230–4.
5. Hood WF, Compton RP, Monahan JB. D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett. 1989;98(1):91–5.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献